Multi center study shows the underscored the need of a uniform approach to the treatment of BCa

A very new study involves Italian research centers found out an aligned and proper approach towards the treatment of the advanced bladder cancer. There are many chances of survival estimates of associated salvage therapies. For this study the researchers got the total of 160 eligible pts across 8 centers nationwide. The median age was 67 years (IQR 39-82) and the most frequent sites of disease at relapse were, nodes 71% (nodes only 43, 26.9%); lung 30%, bone 26% and liver 20%. Bellmunt Score available in 147 out of 160 patients was 0, 1, 2 and 3 in 63 (43%), 59 (40%), 20 (14%) and 5 (3%) patients respectively. Through further analysis brought out the real pattern of treatment. The lead author, Dr. Francesco Atzori, progress in developing new effective drugs in bladder cancer, “In patients who recur or who are refractory to first-line therapy, response rates and outcomes are grim, and to date, no second-line therapy has been clearly established.”